Cargando…

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults

Detalles Bibliográficos
Autores principales:	Diazgranados, Carlos, Hu, Branda, Voloshen, Tim, Dunning, Andrew J., Talbot, H. Keipp, Landolfi, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782117/ http://dx.doi.org/10.1093/ofid/ofu052.767

Ejemplares similares

530 Disease Modulation in Older Adults Vaccinated with High-Dose Versus Standard-Dose Influenza Vaccine
por: Talbot, H. Keipp, et al.
Publicado: (2014)

Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults
por: DiazGranados, Carlos A., et al.
Publicado: (2016)

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
por: Dunning, Andrew J., et al.
Publicado: (2016)

Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients
por: Talbot, H Keipp, et al.
Publicado: (2018)

531 Split-virion compared to Subunit Influenza Trivalent Influenza Vaccines Has Greater Effectiveness in Older Adults
por: Talbot, H. Keipp, et al.
Publicado: (2014)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
por: Gorse, Geoffrey J., et al.
Publicado: (2014)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

1052 Antibody and Cellular Immune Responses to 2011-2012 Seasonal Inactivated Influenza Vaccine in HIV-Infected and Uninfected Children and Young Adults
por: Curtis, Donna, et al.
Publicado: (2014)

650 Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network
por: Clippard, Jessie, et al.
Publicado: (2014)

662 Missed opportunities for influenza vaccination among inpatients with influenza
por: Rao, Suchitra, et al.
Publicado: (2014)

1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
por: Scheifele, David W., et al.
Publicado: (2014)

1075 Effectiveness and Safety of Immunization with Live-attenuated and Inactivated Vaccines for Pediatric Liver Transplantation Recipients
por: Ito, Yoshinori, et al.
Publicado: (2014)

1120 The Impact of Influenza Vaccination in Patients with Cancer on Subsequent Disease during the 2013-2014 Influenza Season
por: Azzi, Jacques, et al.
Publicado: (2014)

LB14. Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
por: Chang, Lee-Jah, et al.
Publicado: (2018)

535 Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network
por: Flannery, Brendan, et al.
Publicado: (2014)

827 The efficacy of single dose peramivir in acute uncomplicated influenza: an integrated subject-level meta-analysis
por: Whitley, Richard, et al.
Publicado: (2014)

1084 Persistence of Meningococcal Antibodies and Response to a Booster Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents
por: Saez-Llorens, Xavier, et al.
Publicado: (2014)

664 Influenza Vaccination in Chronically Ill Children: Taking a Closer Look at LAIV
por: Merckx, Joanna, et al.
Publicado: (2014)

1579 Administering Influenza Vaccine to Patients with Human Immunodeficiency Virus (HIV): Does Timing Matter?
por: Glinka, Elizabeth R., et al.
Publicado: (2014)

1053 Low Uptake of Influenza Vaccine Among University Students: Evaluating Predictors Beyond Cost and Safety Concerns
por: Bednarczyk, Robert, et al.
Publicado: (2014)

1078 Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines
por: Klein, Nicola P., et al.
Publicado: (2014)

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021)

533 Persistence of Antibody to Influenza Hemagglutinin over Two Influenza Seasons
por: Petrie, Joshua G., et al.
Publicado: (2014)

1065 Surveillance and Vaccine Effectiveness Results from the Department of Defense (DoD) Global, Laboratory-Based, Influenza Surveillance Program
por: Thervil, Jeffrey, et al.
Publicado: (2014)

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
por: Schmader, Kenneth E., et al.
Publicado: (2023)

1339 Measles and Mumps Antibody Response in Young Adults after a Third Dose of Measles-Mumps-Rubella Vaccine
por: Fiebelkorn, Amy Parker, et al.
Publicado: (2014)

1112 A Phase III Study of the Safety, Tolerability and Immunogenicity of an Investigational Combination Vaccine against Diphtheria, Tetanus, Pertussis (DTaP5), Polio (IPV), Haemophilus influenzae type b (Hib; PRP-OMPC), and Hepatitis B (HepB) in US Infants
por: Marshall, Gary S., et al.
Publicado: (2014)

1341 The benefit of early influenza antiviral treatment of pregnant women hospitalized with laboratory-confirmed influenza
por: Oboho, Ikwo, et al.
Publicado: (2014)

1060 The Effect of Live Attenuated Influenza Vaccine (LAIV) on Bacterial Colonization in Healthy 2-4 Year Old Children. A Randomised Controlled Study
por: Thors, Valtyr, et al.
Publicado: (2014)

663 Physician Electronic Best Practice Alerts vs Nursing and Pharmacist-Driven Screening and Ordering: Which System Delivers More Inpatient Influenza Vaccines?
por: Guzman-Cottrill, Judith, et al.
Publicado: (2014)

Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial
por: Pepin, Stephanie, et al.
Publicado: (2021)

Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children
por: Nolan, Terry, et al.
Publicado: (2009)

2322. Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial
por: Hsiao, Amber, et al.
Publicado: (2022)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
por: Carregaro, Rodrigo Luiz, et al.
Publicado: (2023)

1103 Immunogenicity of 13-valent conjugate pneumococcal vaccine in patients 50 years or older with end stage renal disease on dialysis
por: Mitra, Subhashis, et al.
Publicado: (2014)

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

1104 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Immunogenicity in the Community Acquired Pneumonia Immunization Trial In Adults (CAPiTA)
por: Van Deursen, Anna M.M., et al.
Publicado: (2014)

1057 Factors Associated with Influenza A (H1N1)pdm09 (pH1N1) Vaccine Failure among Children Aged 5-17 Years
por: Mclean, Huong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vn8tvm36eibtvp1o1ck95a83s5